<DOC>
	<DOCNO>NCT00589914</DOCNO>
	<brief_summary>The purpose study demonstrate effectiveness paliperidone palmitate patient Schizophrenia .</brief_summary>
	<brief_title>Comparison Paliperidone Palmitate RISPERDAL CONSTA Patients With Schizophrenia</brief_title>
	<detailed_description>This randomize ( patient assign treatment group chance ) , double-blind ( patient study staff know treatment assignment ) study paliperidone palmitate compare RISPERDAL CONSTA ( Risperidone Long-Acting Intramuscular Injection ) adult patient schizophrenia . The total duration study approximately 14 week . For patient without source documentation tolerability oral ( mouth ) risperidone paliperidone Extended Release ( ER ) tablet , injectable RISPERDAL CONSTA paliperidone palmitate , patient currently take another antipsychotic , minimum 4 day maximum 6 day oral paliperidone ER treatment dosage 6 mg/day administer tolerability test first injection double-blind ( DB ) study drug ( paliperidone palmitate RISPERDAL CONSTA ) . During DB period , study drug administer patient intramuscular ( i.m . ) injection . Paliperidone palmitate ( PP ) 150mg equivalent ( eq ) ( RISPERDAL CONSTA placebo ) Baseline ( BL ) ( Day 1 ) , 100mg eq Visit ( V ) 4 ( Day 8 ) , 50 100mg eq V7 ( Day 36 ) , 50,100 , 150mg eq V9 ( Day 64 ) RISPERDAL CONSTA ( RC ) 25mg V4 V6 ( Day 22 ) , 25 37.5mg V7 , 25 , 37.5 , 50mg V9 give i.m . injection . Patients RC group also take risperidone tablet ( 1-6 mg/day ) BL 28 day give injection PP placebo BL , V1 , V7 , V9 .</detailed_description>
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Paliperidone Palmitate</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<criteria>Meet diagnostic criterion schizophrenia accord Diagnostic Statistical Manual Mental Disorders , Fourth Edition ( DSMIV ) criterion specify protocol least 1 year screen Prior medical record , write documentation verbal information obtain previous psychiatric provider obtain investigator must consistent diagnosis schizophrenia A total PANSS score 60 120 , inclusive , screening baseline ; Body mass index ( BMI ) screen visit BMI least 17 kg/m2 Female patient must postmenopausal least 2 year , surgically sterile , abstinent , , sexually active , practice effective method birth control study entry throughout study specify protocol . Women childbearing potential must negative serum betahuman chorionic gonadotropin ( b hCG ) pregnancy test result screen . Patient unable provide consent involuntarily commit psychiatric hospitalization ; A primary , active DSMIV diagnosis Axis I schizophrenia A DSMIV diagnosis active substance dependence within 3 month screen ( nicotine caffeine exclusionary ) History treatment resistance define failure respond 2 adequate treatment different antipsychotic medication ( adequate treatment define minimum 6 week maximum tolerated dosage ) Relevant history current presence significant unstable cardiovascular , respiratory , neurologic ( include seizure significant cerebrovascular disease ) , renal , hepatic , hematologic , endocrine , immunologic , systemic disease include history neuroleptic malignant syndrome ; History severe preexist gastrointestinal narrowing inability swallow oral study drug whole aid water ( apply patient require oral tolerability ) Significant risk suicidal violent behavior , clinically assessed investigator ; History lifethreatening allergic reaction drug ; Known suspect hypersensitivity intolerance risperidone , paliperidone , 20 % Intralipid , excipients ( e.g. , soybean oil , egg yolk , phospholipid , glycerol ) Have receive experimental drug experimental biologic , use experimental medical device within 6 month screen ; History active malignancy within previous 5 year , exception basal cell carcinomas Women pregnant breastfeeding planning become pregnant uring study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
	<keyword>Schizophrenia</keyword>
	<keyword>long-acting injectable antipsychotic medication</keyword>
</DOC>